BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 28224298)

  • 1. The performance of the mSEPT9 assay is influenced by algorithm, cancer stage and age, but not sex and cancer location.
    Song L; Jia J; Yu H; Peng X; Xiao W; Gong Y; Zhou G; Han X; Li Y
    J Cancer Res Clin Oncol; 2017 Jun; 143(6):1093-1101. PubMed ID: 28224298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.
    Warren JD; Xiong W; Bunker AM; Vaughn CP; Furtado LV; Roberts WL; Fang JC; Samowitz WS; Heichman KA
    BMC Med; 2011 Dec; 9():133. PubMed ID: 22168215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Methylenetetrahydrofolate Reductase rs1801133 Gene Polymorphism with Cancer Risk and Septin 9 Methylation in Patients with Colorectal Cancer.
    Huang Y; Su T; Duan Q; Wei X; Fan X; Wan J; Liu L; Dian Z; Zhang G; Sun Y; Zhou T; Xu Y
    J Gastrointest Cancer; 2024 Jun; 55(2):778-786. PubMed ID: 38252186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Septin9 versus fecal immunochemical testing for colorectal cancer screening: a prospective multicenter study.
    Johnson DA; Barclay RL; Mergener K; Weiss G; König T; Beck J; Potter NT
    PLoS One; 2014; 9(6):e98238. PubMed ID: 24901436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The stool DNA test is more accurate than the plasma septin 9 test in detecting colorectal neoplasia.
    Ahlquist DA; Taylor WR; Mahoney DW; Zou H; Domanico M; Thibodeau SN; Boardman LA; Berger BM; Lidgard GP
    Clin Gastroenterol Hepatol; 2012 Mar; 10(3):272-7.e1. PubMed ID: 22019796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Circulating Tumor DNA Methylation in Diagnosis of Colorectal Cancer.
    Xu F; Yu S; Han J; Zong M; Tan Q; Zeng X; Fan L
    Clin Transl Gastroenterol; 2021 Aug; 12(8):e00386. PubMed ID: 34382948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating-tumour DNA methylation of HAND1 gene: a promising biomarker in early detection of colorectal cancer.
    Shavali M; Moradi A; Tahmaseb M; Mohammadian K; Ganji SM
    BMC Med Genomics; 2024 Apr; 17(1):117. PubMed ID: 38689296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review of blood diagnostic markers in colorectal cancer.
    Nikolaou S; Qiu S; Fiorentino F; Rasheed S; Tekkis P; Kontovounisios C
    Tech Coloproctol; 2018 Jul; 22(7):481-498. PubMed ID: 30022330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum methylation of GALNT9, UPF3A, WARS, and LDB2 as noninvasive biomarkers for the early detection of colorectal cancer and advanced adenomas.
    Gallardo-Gómez M; Rodríguez-Girondo M; Planell N; Moran S; Bujanda L; Etxart A; Castells A; Balaguer F; Jover R; Esteller M; Cubiella J; Gómez-Cabrero D; De Chiara L
    Clin Epigenetics; 2023 Oct; 15(1):157. PubMed ID: 37794510
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Laven-Law G; Kichenadasse G; Young GP; Symonds EL; Winter JM
    Biomarkers; 2024 Jun; 29(4):194-204. PubMed ID: 38644767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylated
    Hitchins MP; Vogelaar IP; Brennan K; Haraldsdottir S; Zhou N; Martin B; Alvarez R; Yuan X; Kim S; Guindi M; Hendifar AE; Kalady MF; DeVecchio J; Church JM; de la Chapelle A; Hampel H; Pearlman R; Christensen M; Snyder C; Lanspa SJ; Haile RW; Lynch HT
    BMJ Open Gastroenterol; 2019; 6(1):e000299. PubMed ID: 31275589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of the methylated SEPT9 test for the early detection of colorectal cancer: a systematic review and meta-analysis of diagnostic test accuracy.
    Hariharan R; Jenkins M
    BMJ Open Gastroenterol; 2020; 7(1):e000355. PubMed ID: 32128229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detecting colorectal cancer using genetic and epigenetic biomarkers: screening and diagnosis.
    Rezkitha YAA; Panenggak NSR; Lusida MI; Rianda RV; Mahmudah I; Pradana AD; Uchida T; Miftahussurur M
    J Med Life; 2024 Jan; 17(1):4-14. PubMed ID: 38737656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External quality assessment for detection of colorectal cancer by Septin9 DNA methylation in clinical laboratories.
    Chang L; Wang D; Han Y; Diao Z; Chen Y; Li J; Zhang R
    Clin Chim Acta; 2024 Jan; 552():117663. PubMed ID: 38008152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advance in plasma SEPT9 gene methylation assay for colorectal cancer early detection.
    Wang Y; Chen PM; Liu RB
    World J Gastrointest Oncol; 2018 Jan; 10(1):15-22. PubMed ID: 29375744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SEPT9 gene methylation assay is capable of detecting colorectal adenoma in opportunistic screening.
    Song L; Peng X; Li Y; Xiao W; Jia J; Dong C; Gong Y; Zhou G; Han X
    Epigenomics; 2017 May; 9(5):599-610. PubMed ID: 28470092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: A meta-analysis.
    Song L; Jia J; Peng X; Xiao W; Li Y
    Sci Rep; 2017 Jun; 7(1):3032. PubMed ID: 28596563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Invasive Colorectal Cancer Screening: An Overview.
    Tepus M; Yau TO
    Gastrointest Tumors; 2020 Jul; 7(3):62-73. PubMed ID: 32903904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant DNA Methylation of
    Zhao G; Liu X; Liu Y; Li H; Ma Y; Li S; Zhu Y; Miao J; Xiong S; Fei S; Zheng M
    Front Genet; 2020; 11():643. PubMed ID: 32625237
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.